Evidence map›Paper›PMID 27407105›Full record

ArticleNucleic acids research2016

DDK dependent regulation of TOP2A at centromeres revealed by a chemical genetics approach.

Kevin Z L Wu, Guan-Nan Wang, Jennifer Fitzgerald, Huong Quachthithu, Michael D Rainey, Angela Cattaneo, Angela Bachi, Corrado Santocanale

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Primary neurons can enter M-phase.Scientific reports · 2019
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Kevin Z L WuCentre for Chromosome Biology, School of Natural Sciences, National University of Ireland Galway, Ireland.
Guan-Nan WangCentre for Chromosome Biology, School of Natural Sciences, National University of Ireland Galway, Ireland.
Jennifer FitzgeraldCentre for Chromosome Biology, School of Natural Sciences, National University of Ireland Galway, Ireland.
Huong QuachthithuCentre for Chromosome Biology, School of Natural Sciences, National University of Ireland Galway, Ireland.
Michael D RaineyCentre for Chromosome Biology, School of Natural Sciences, National University of Ireland Galway, Ireland.
Angela CattaneoIFOM-FIRC Institute of Molecular Oncology, Milan 20139, Italy.
Angela BachiIFOM-FIRC Institute of Molecular Oncology, Milan 20139, Italy.
Corrado SantocanaleCentre for Chromosome Biology, School of Natural Sciences, National University of Ireland Galway, Ireland corrado.santocanale@nuigalway.ie.
Ollscoil na Gaillimhe – University of Galway · IEFIRC Institute of Molecular Oncology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In eukaryotic cells the CDC7/DBF4 kinase, also known as DBF4-dependent kinase (DDK), is required for the firing of DNA replication origins. CDC7 is also involved in replication stress responses and its depletion sensitises cells to drugs that affect fork progression, including Topoisomerase 2 poisons. Although CDC7 is an important regulator of cell division, relatively few substrates and bona-fide CDC7 phosphorylation sites have been identified to date in human cells. In this study, we have generated an active recombinant CDC7/DBF4 kinase that can utilize bulky ATP analogues. By performing in vitro kinase assays using benzyl-thio-ATP, we have identified TOP2A as a primary CDC7 substrate in nuclear extracts, and serine 1213 and serine 1525 as in vitro phosphorylation sites. We show that CDC7/DBF4 and TOP2A interact in cells, that this interaction mainly occurs early in S-phase, and that it is compromised after treatment with CDC7 inhibitors. We further provide evidence that human DBF4 localises at centromeres, to which TOP2A is progressively recruited during S-phase. Importantly, we found that CDC7/DBF4 down-regulation, as well S1213A/S1525A TOP2A mutations can advance the timing of centromeric TOP2A recruitment in S-phase. Our results indicate that TOP2A is a novel DDK target and have important implications for centromere biology.

Indexed as

Antigens, NeoplasmCell Cycle ProteinsCentromereDNA-Binding ProteinsDNA ReplicationDNA Topoisomerases, Type IIHumansPhosphorylationPoly-ADP-Ribose Binding ProteinsProtein BindingProtein Serine-Threonine KinasesReplication OriginS PhaseAntigens, NeoplasmCDC7 protein, humanCell Cycle ProteinsDBF4 protein, humanDNA-Binding ProteinsDNA Topoisomerases, Type IIPoly-ADP-Ribose Binding ProteinsProtein Serine-Threonine KinasesTOP2A protein, human

Identifiers

PMID27407105
PMCPMC5062981
OpenAlexW2474010245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.